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 • EDITORIAL
Terrestrial life as we know it would not have evolved were it not for the trabeculated myocardium (1). Tra-
beculae are nontrivial, and we know this because (a) the 
dense trabecular meshwork that occludes the embryonic 
ventricle acts as both the functional equivalent and the 
cellular ascendant of the Purkinje fiber network in mam-
mals and birds (2), (b) healthy development of the mature 
working myocardium is tightly linked to the events taking 
place in the trabeculated layer, and (c) disruption of tra-
becular development leads to extreme hypotrabeculation 
that is incompatible with life and is frequently lethal in 
the embryonic mouse. To learn all this about the intricate 
trabecular meshwork, we have to leave the linear platonic 
world and get complex. In our quest for better understand-
ing and models of the real world (here, the cardiovascular 
system), we discovered an ally to partner with imaging—
mathematical fractal analysis.
Thus, we welcome the elegant work of Dawes and col-
leagues (3) in this issue of Radiology, which reports on a 
retrospective fractal analysis of the right ventricle (RV) in 
patients with pulmonary hypertension and healthy con-
trol subjects. Although fractal analysis of the RV had been 
previously used in the fetal mouse to understand cardio-
morphogenesis (2), it had not been applied to the human 
RV. Here, with cardiac MRI, the fractal method appears 
reproducible (interobserver intraclass correlation of 0.97, 
not including test-retest correlation) and correlates with 
RV afterload; however, it cannot be used to independently 
predict survival when compared with other prognostic 
determinants (ie, age, sex, ethnicity, RV size or function, 
brain natriuretic peptide level, 6-minute walking distance, 
functional class, or invasive hemodynamics).
Pulmonary hypertension, nominally a disease of the 
pulmonary vasculature, seems to have survival determined 
by the cardiac response (ie, RV function), at least as we 
can currently measure. The fractal dimension (FD) of the 
RV was inversely correlated with RV ejection fraction and 
stroke volume. Similar to what has already been shown for 
the left ventricle (4), where each 10 mL of end-diastolic 
volume associates with 0.004 greater FD (P , .001), 
Dawes et al found a significant positive correlation (r = 
0.32, P , .001) between RV volume and FD. These data 
suggest that trabeculae increase in either number or size as 
the heart dilates; however, these results must be interpreted 
with caution. FD measures how completely segmented 
endocardial contours fill the two-dimensional image space 
of the ventricular lumen. For a fixed volume of trabeculae 
(assuming no trabecular hypertrophy and no de novo 
trabecular formation), RV dilatation alone should theoreti-
cally reduce the FD for a given section. A dilated volume-
overloaded RV from tricuspid or pulmonary regurgitation 
is a frequently encountered complication of longstanding 
pulmonary hypertension; therefore, it should have a lower 
FD compared with FD in an RV with the same amount 
of trabeculae but a smaller cavity size. In the current work 
on pulmonary hypertension, Dawes et al do not correct 
RV FD for coexistent volume overload, so it is possible 
that FD is being systematically underestimated precisely 
in the subgroup of patients with more advanced pulmo-
nary hypertension and poorer health in the right side of 
the heart. Such confounding would ultimately undermine 
the prognostic performance of the fractal biomarker and 
could explain why RV FD did not retain predictive ability 
at multivariable testing.
Recent work using ellipsoidal two-dimensional visual 
models (5) has highlighted the close interaction between 
trabecular load, end-diastolic volume, and strain, so inter-
preting FD as a percentage of end-diastolic volume may be 
superior to FD alone. For a fixed amount of cavity strain, 
a larger number of trabeculations (or chunkier trabeculae) 
can contribute to ejecting more blood out of the ventricle, 
as their systolic coalescence helps reduce end-systolic vol-
ume, thus increasing stroke volume. So then, is RV hyper-
trabeculation a good thing or a bad thing? We think both. 
It is good because it allows the distressed heart to generate 
higher stroke volumes for a given cavity size, buying time 
before the establishment of frank right-sided heart failure. 
It is bad because if the heart were unstressed to begin with, 
trabeculation would not need to increase.
Interestingly, the difference between patients who sur-
vive pulmonary hypertension and those who die from 
this disease is greater for noncompacted RV mass index 
(P = .04) than for maximal apical FD (P = .05). We are 
not told whether noncompacted RV mass index corre-
lated better with pulmonary vascular resistance than did 
the FD, but it raises the question of whether the pro-
portion of trabeculated myocardium compared with the 
rest of the muscle matters more for survival in pulmonary 
hypertension than the FD.
Dawes et al postulate that the increased RV FD mea-
sured in patients with pulmonary hypertension is simply 
a reflection of RV trabecular hypertrophy (and, of course, 
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papillary muscle and moderator band hypertrophy as well). How-
ever, whether the afterloaded right side of the heart is instead or 
also sprouting de novo trabeculae, and thus further modulating 
its endocardial landscape, remains to be tested. The ability of the 
distressed ventricle to generate de novo trabeculae, if indeed this 
is what is happening, could be the key to unshackling the regen-
erative potential of the adult human myocardium. However, the 
majority of work on myocardial trabeculae in adults overlooks 
this fundamental mechanistic question: if a distressed adult ven-
tricle can generate de novo trabeculae to maintain stroke vol-
ume, how are these trabeculae arising, and can this process be 
harnessed to increase stroke volume in the failing heart?
For years, developmental biologists were plagued by an analo-
gous puzzle—trabecular fate during cardiac embryogenesis—be-
fore they seemed to have finally cracked it. We are referring to the 
previously upheld theory of developmental compaction. By study-
ing the patterns of proliferation and gene expression in chamber-
forming stages of the human heart and the mouse heart and con-
firming the proliferation that occurs in the compact myocardial 
layer (6), developmental biologists have clarified the origins of 
ventricular wall thickening before birth. However, this alone was 
not sufficient to prove the origins of ventricular wall thickening, 
nor did it enable observers to rule out compaction of trabeculae, 
per se. The proof required to disprove the compaction model of 
ventricular development requires genetic lineage tracing of the fate 
of trabecular tissue. There have now been some studies that have 
seemed to address this. Miquerol et al (7) used a transgenic ven-
tricular conduction system reporter mouse line to study the ori-
gins of the conduction system and showed that at embryonic day 
10.5, labeled descendants of trabecular cells are found in both the 
Purkinje fibers and the compact wall; however, by embryonic day 
16.5, the lineages of the mature working myocardium and Pur-
kinje fibers have separated. This suggests that as development pro-
ceeds, trabeculae become distinct from and do not coalesce into 
the compact ventricular wall (8). We will need similar approaches 
to unpick the trajectories of trabecular formation and hypertrophy 
taking place in the adult human heart.
To conclude, the origins and fate of trabeculae across the hu-
man myocardial life course and in response to disease are still 
being elucidated, but what potentially stands out from the cur-
rent work is the extraordinary trabecular plasticity of the adult 
human heart. For a long time, we have been concentrating our 
efforts on biopsy of the compact adult myocardium, but perhaps 
it is the lower-hanging fruit—the unassuming trabeculae—that 
we ought to be sampling and studying at scale.
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